financetom
Business
financetom
/
Business
/
BRIEF-Dorchester Minerals, L.P. Announces Acquisition Of Mineral Interests
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Dorchester Minerals, L.P. Announces Acquisition Of Mineral Interests
Mar 28, 2024 2:36 PM

March 28 (Reuters) - Dorchester Minerals LP ( DMLP ):

* DORCHESTER MINERALS, L.P. ( DMLP ) ANNOUNCES ACQUISITION OF MINERAL

INTERESTS

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Match Group Names Laura Jones, Spencer Rascoff to Board
Match Group Names Laura Jones, Spencer Rascoff to Board
Mar 25, 2024
09:00 AM EDT, 03/25/2024 (MT Newswires) -- Match Group ( MTCH ) said Monday it named Laura Jones and Spencer Rascoff to its board of directors after a constructive dialogue with Elliott Investment Management. Jones is the chief marketing officer at Instacart, while Rascoff co-founded Zillow and has served as its chief executive. The online dating service company said it...
AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder
AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder
Mar 25, 2024
09:00 AM EDT, 03/25/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Monday the US Food and Drug Administration has approved the Ultomiris C5 complement inhibitor to treat adult patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Neuromyelitis optica spectrum disorder, or NMOSD, is a rare autoimmune disease that affects the central nervous system, including the spine and optic nerves....
AbbVie to bolster immunity illness drug pipeline with Landos deal
AbbVie to bolster immunity illness drug pipeline with Landos deal
Mar 25, 2024
(Reuters) -AbbVie ( ABBV ) will buy drug developer Landos Biopharma ( LABP ) for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses, the companies said on Monday. Landos is currently conducting a mid-stage study of its lead experimental drug NX-13 in a type of an inflammatory bowel disease...
Ingersoll Rand Dives Deep Into Life Sciences With ~$2.3B ILC Dover Acquisition
Ingersoll Rand Dives Deep Into Life Sciences With ~$2.3B ILC Dover Acquisition
Mar 25, 2024
Industrial products maker Ingersoll Rand Inc ( IR ) has entered into an agreement to acquire ILC Dover from the investment firm New Mountain Capital, LLC. The deal includes an upfront cash purchase price of about $2.325 billion and an earnout tied to select operating efficiency metrics in 2024. At its maximum payout, the earnout increases the 17x upfront purchase multiple by less than one...
Copyright 2023-2026 - www.financetom.com All Rights Reserved